A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.
Junliang ChenHuaitao WangLei ZhouZhihao LiuXiaodong TanPublished in: Journal of clinical laboratory analysis (2022)
The dual-marker panel consisting of CA199 and CTC number can significantly improve upon the diagnostic performance of CA199 alone, highlighting the promising clinical utilization as an effective strategy for PDAC surveillance.